Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v20-EN Version v9-FR
Language English French
Date Updated 2022-12-24 2021-12-08
Drug Identification Number 02444739 02444739
Brand name ZOLEDRONIC ACID FOR INJECTION ZOLEDRONIC ACID FOR INJECTION
Common or Proper name Zoledronic Acid Zoledronic Acid
Company Name JUNO PHARMACEUTICALS CORP. JUNO PHARMACEUTICALS CORP.
Ingredients ZOLEDRONIC ACID ZOLEDRONIC ACID
Strength(s) 4MG 4MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 5mL Vial 5mL Vial
ATC code M05BA M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-09-15 2021-09-15
Estimated end date 2022-12-23 2022-12-31
Actual end date 2022-12-23
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Discontinuation report initiated
Health Canada comments